Fc Fragment of IgE Receptor Ig (FCER1G) acts as a key gene involved in cancer immune infiltration and tumour microenvironment

Abstract

Although recent studies have revealed the relationship between Fc Fragment of IgE Receptor Ig (FCER1G) and human tumours, there is still a lack of a more comprehensive pan-cancer analysis of FCER1G as an immune-related gene. In this study, we investigated the expression pattern and prognostic value of FCER1G based on multiple databases. Subsequently, we further explored the role of FCER1G in tumour proliferation and metastasis, as well as its genomic alterations and DNA methylation levels, we next assessed the association between FCER1G and the immune infiltrating cells of the tumour microenvironment in different cancers and verified it by immunohistochemical staining. The correlation between FCER1G and immune checkpoint genes expression and its predictive power in the immune checkpoint blockade treatment cohorts were used to evaluate the importance of FCER1G in immunotherapy. Enrichment analysis of FCER1G-associated partners was also performed. In addition, we substantiated the expression of FCER1G in specific cell types of different tumours using singlecell RNA sequencing data from different databases. Our research results showed that FCER1G is up-regulated in most tumour. Positive associations were found between FCER1G expression and tumour prognosis, proliferation, and metastasis, we also found that FCER1G is closely related to the tumour microenvironment and tumour immunity. Moreover, FCER1G-associated partners were enriched in pathways associated with neutrophils activation. Finally, we confirmed that FCER1G was mainly expressed in monocyte/macrophages of the tumour microenvironment. In conclusion, our findings provided a comprehensive understanding of FCER1G in oncogenesis and tumour immunology among various tumours and demonstrated its potential value in prognosis prediction and tumour immunotherapy.K E Y W O R D S cancer immunotherapy, FCER1G, pan-cancer, tumour microenvironment Riwei Yang and Zude Chen contributed equally to this work.

Comprehensive landscape of immune-based classifier related to early diagnosis and macrophage M1 in spinal cord injury

“…FCER1G is an important inflammation-related molecule that encodes the Fc receptor γ-chain (FcRγ). FcRY contains an immune receptor tyrosine-based activator motif (ITAM) which is a key signaling transducer of multiple pathways mediating autoimmunity and chronic inflammation [33]. Numerous studies have found that FCER1G is expressed on the surface of various immune cells, including neutrophils, macrophages, eosinophils, etc., [34,35].…”

Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma

“…The expression of FCER1G increases within many cancers. FCER1G expression was positively associated with tumor prognostic outcome, growth, and migration; also, FCER1G was closely related to tumor immunity and tumor microenvironment (TME) [ 33 ]. FCGR3A usually shows upregulated in pan-cancer [ 34 ].…”

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma

“…However, for gliomas of the central nervous system, the results were reversed 32 . The results 33 , 34 of two pan-cancer studies suggest that FCER1G is involved in the immune infiltration process of tumors and may be a potential immunotherapeutic target. Our experiment confirmed that it was highly expressed in the sinuses of normal tissue adjacent tumor, while the expression of tumors was reduced.…”